Building on decades of manufacturing and technical experience, TriLink is expanding our CDMO services to offer DNA plasmid production. Our optimized plasmid manufacturing process is the right start for mRNA production and is purposefully designed to ensure the critical quality attributes for successful mRNA applications. Reduce your time to the clinic with our streamlined end-to-end mRNA solutions. TriLink plasmid DNA production serves a wide variety of therapeutic needs; from mRNA therapeutics and vaccine technologies to novel gene editing and cell therapy applications, including CAR-T therapies and lentivirals.
Be among the first to learn about TriLink plasmid manufacturing and complete mRNA solutions. Download our comprehensive plasmid manufacturing brochure
Plasmid manufacturing takes place in our seven newly-built suites, including 3 cGMP suites. The flexibility of this multi-room setup enables us to support both small and medium-scale production lines, as well as simultaneous production.
TriLink offers flexible manufacturing grades to suit your program requirements. Full GMP production is available, as well as our customizable GMPLink™ grade and discovery grade. GMPLink offers the benefits of GMP at a cost savings, and is a viable option for up to pre-clinical programs.
TriLink plasmid manufacturing process is built on nearly 20 years of process development experience, setting your project up for success.